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presumably tested in other laborato-
ries involved, but we are not aware of
any publications to this end. The lack
of evidence for laboratory-acquired
infection with A H2N2 in our study
suggests that the risk was low under
controlled laboratory conditions.
However, only a large-scale serologic
study (which might still feasibly be
undertaken) could further substantiate
this finding. 
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Methicillin-
resistant
Staphylococcus
aureus in Cat and
Owner 
To the Editor: A 3-year-old,
neutered male, domestic shorthaired
cat was referred for treatment to a vet-
erinary specialty clinic in San
Francisco, California, with a 1-year
history of multifocal patches of crust-
ed and well-demarcated ulcers on the
trunk. Initially, small crusts suspected
to be associated with flea allergy and
pyoderma were present; however,
response was poor to multiple treat-
ments, including repeated corticos-
teroid therapy and antimicrobial ther-
apy with amoxicillin–clavulanic acid
and enrofloxacin. The owner reported
having skin abscesses and pneumonia
3 months earlier, although no microbi-
ologic testing was performed.
Cytologic evaluation of exudate
from the cat’s lesions identified neu-
trophils and eosinophils with engulfed
cocci. Leukocytosis with eosinophilia
was found on a complete blood cell
count. No notable abnormalities were
present on thoracic radiograph,
abdominal ultrasonograph, urinalysis,
and tests for feline leukemia and
immunodeficiency virus. Skin biopsy
specimens were collected for histo-
logic examination, and swabs of the
exudates were submitted for bacterial
culture. Histopathologic findings
demonstrated ulcers and dermal gran-
ulation tissue with linearly arranged
eosinophils, mast cells, neutrophils,
and plasma cells between dense,
homogeneous collagen bundles (scle-
rosing dermatitis). This pattern of
inflammation is distinct from most
staphylococcal infections of the skin,
and it has been suggested that this
uncommon histologic finding in cats
is associated with methicillin-resistant
staphylococcal infection (1).
Methicillin-resistant  Staphylo-
coccus aureus (MRSA) was isolated
1998 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 12, December 2006
Figure. Titers of antibodies to influenza A H2N2 virus in laboratory personnel (n = 25; 13
born before 1969) and a comparison group born before 1969 (n = 32). The age listed is
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from the skin lesions. Identification
was confirmed by detection of peni-
cillin-binding protein 2a (PBP2a) by
latex agglutination test (PBP2′ Test
Kit, Oxoid, Hants, UK). Typing was
performed by SmaI pulsed-field gel
electrophoresis as previously
described (2), and the isolate was
classified as the USA300 clone.
Genes encoding production of the
Panton-Valentine leukocidin (PVL)
were identified by real-time PCR (3).
The isolate was susceptible to chlo-
ramphenicol, tetracycline, trimetho-
prim-sulfamethoxazole, and van-
comycin, but resistant to β-lactams,
enrofloxacin, and erythromycin. After
identification of MRSA in the cat,
swabs of the anterior nares were col-
lected from the owner and the cat, and
MRSA was identified in specimens
from both. All isolates were indistin-
guishable.
This is the first report of isolation
of USA300 MRSA from a household
pet. USA300 is a community-associ-
ated clone that has disseminated
widely throughout North America and
Europe (4,5) and is reaching epidemic
proportions in many regions. MRSA
is becoming an important cause of
skin and soft tissue infection in per-
sons in the community (4,5) and has
also been implicated in invasive
infections such as necrotizing pneu-
monia (6). This clone possesses genes
for PVL production, which may be an
important factor in its apparent viru-
lence (4,5). Additional characteriza-
tion of the isolates from this study was
not performed; however, USA300 has
previously been reported to carry
staphylococcal cassette chromosome
mec (SCCmec) type IVa and classi-
fied as sequence type 8 (ST8) by mul-
tilocus sequence typing (4,5).
Reports of MRSA infection and
colonization in pets have increased
dramatically in the past few years
(3,7–9). Although this rise may be
partially the result of increased testing
and reporting, MRSA is definitely
emerging in pet populations through-
out the world. The role of pets in
transmission of MRSAis still unclear;
however, recent evidence suggests
that MRSA can be transmitted
between persons and their pets, in
both directions (9,10). Reports of
MRSA infection and colonization in
pets have indicated that pets tend to be
infected with isolates that are consis-
tent with clones that are predominant
in the human population in their area
(7–9). Accordingly, USA100 account-
ed for initial isolations of MRSA in
pets in North America (9). The simi-
larity between pet and human isolates
has led to speculation that pet MRSA
is closely linked to human MRSAand
that the source of MRSA in pets may
often be colonized humans. If this is
the case, it is not surprising that
USA300 would emerge as a cause of
disease in pets as it increases in preva-
lence in the human population.
Considering the rapid dissemination
of USA300 in humans in the United
States, particularly in California,
where it is the predominant communi-
ty-associated clone, finding USA300
in a household pet in that state is not
unexpected.
Because indistinguishable isolates
were collected from the owner and the
infected cat, MRSA likely was trans-
mitted between species in the house-
hold. However, while it is tempting to
assume that the owner was the source
of infection because of the owner’s
previous history of a soft tissue infec-
tion, this cannot be definitively deter-
mined on the basis of the timing of
sampling in this case.
MRSA appears to be emerging as
an important veterinary and zoonotic
pathogen, and the epidemiology of
MRSA in household pets may take a
parallel course to that in humans.
Ongoing MRSA surveillance in ani-
mals is required, including proper
testing of specimens from clinically
affected animals and surveillance for
colonization. The potential for trans-
mission of this clone between humans
and pets should also be evaluated to
clarify its epidemiology and to facili-
tate development of measures to
reduce household transmission.
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Community-
associated
Methicillin-
resistant
Staphylococcus
aureus, Colombia
To the Editor: Methicillin-resist-
ant Staphylococcus aureus (MRSA) is
an established nosocomial pathogen
worldwide but more recently has
emerged as a highly virulent organism
in the community, particularly in the
United States (1–3). In Latin America,
community-associated MRSA (CA-
MRSA) has only been described in
the southern area of the continent
(Uruguay and Brazil) (4,5). No
reports from the Andean region are
available. We describe 2 cases of CA-
MRSA causing soft-tissue infections
(1 severe) in Colombia. 
The first case was in a 19-year-old
man with a history of trauma to the
left side of his body 1 week before
admission after a fall. On admission,
he complained of 2 days of fever,
malaise, erythema and induration in
the left hemithorax extending to the
left thigh, and purulent secretion from
an excoriation on the anterior aspect
of the left thigh. He had no previous
medical history. No previous hospital-
izations or antimicrobial drug pre-
scriptions were documented, nor did
he report relatives with history of
recent hospitalizations. Vital signs at
admission were normal except for
fever (39°C), and physical examina-
tion showed induration and erythema
in the region of left hemithorax
extending to the thigh, with an area of
excoriation in the same thigh with
purulent discharge. Laboratory evalu-
ation showed a leukocyte count of
23.1×109/L (86% neutrophils with 2%
band forms) and elevated C-reactive
protein levels. 
The patient was hospitalized.
Because necrotizing fascitis was sus-
pected, intravenous ampicillin-sul-
bactam (12 g per day) was started, and
surgical evaluation was requested.
The patient underwent surgical
debridement of the left thigh, left
hemiabdomen, and hemithorax,
which confirmed the diagnosis of
necrotizing fascitis. Intravenous van-
comycin (1 g every 12 h) was added
to the regimen, and the patient was
transferred to the intensive care unit.
After several surgical debridements,
the patient underwent placement of
cutaneous-muscle grafts. He was dis-
charged from the hospital without
complications after completing 14
days of antimicrobial agents.
The second case involved a 53-
year-old man with no history of pre-
vious hospitalizations who reported
to the emergency department with a
3-day history of fever, pain, swelling,
and warm sensation on the posterior
aspect of the left thigh. Adiagnosis of
cellulitis was made, and cephalexin
(500 mg every 6 h) and gentamicin
(160 mg intramuscularly every 24 h)
were administered for 7 days without
improvement. He returned to the hos-
pital with worsening symptoms, an
area of induration of 4×4 cm in the
thigh, and purulent discharge.
Drainage of the lesion was per-
formed, and oral trimethoprim and
sulfamethoxazole (160 and 800 mg,
respectively, every 12 h) was started.
His clinical signs and symptoms
completely resolved after 7 days of
therapy.
Tissue culture from secretions
from both patients showed gram-pos-
itive cocci in clusters on the Gram
stain, and subsequent cultures yielded
MRSA. Species identification and
presence of the mecA gene were con-
firmed by PCR, as described previ-
ously (6). MICs were determined by
using the agar diffusion test, accord-
ing to Clinical and Laboratory
Standards Institute recommendations
(7). Both organisms were susceptible
to vancomycin, teicoplanin, chloram-
phenicol, linezolid, ciprofloxacin,
gentamicin, and rifampin. The isolate
from the second patient was resistant
to erythromycin and susceptible to
clindamycin, exhibited the M pheno-
type on the double-disk diffusion
assay (D test), and harbored the msrA
gene, encoding an efflux pump (8). In
contrast, the first isolate was suscepti-
ble to both erythromycin and clin-
damycin and resistant to tetracycline
(MIC >64 µg/mL). Because infec-
tions caused by CA-MRSA isolated
elsewhere are associated with the
presence of the lukF gene encoding
the Panton-Valentine leukocidin toxin
and the staphylococcal chromosome
cassette mec (SCCmec) type IV, the
presence of both was evaluated by
PCR, as described previously (9).
Both isolates were positive for lukF
and harbored the SCCmec type IV.
The molecular epidemiology of
healthcare-related MRSA in
Colombia has changed during the past
3 years (10), but no reports of CA-
MRSAhad emerged. We believe these
to be the first reports of CA-MRSAin
Colombia with similar characteristics
to those reported elsewhere. No risk
factors associated with healthcare-
associated MRSA were found in
either of these patients, and the
patients were not epidemiologically
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